MedTrace Logo

Determination of Risk Factors and Awareness Associated With Development of Neuromuscular Scoliosis

NCT04764812 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 288

Last updated 2022-02-21

No results posted yet for this study

Summary

Neuromuscular diseases caused by disruption of the normal conduction relationship between nerve system, neuromuscular junction, and muscles cause scoliosis as a secondary deformity. Neuromuscular scoliosis progresses due to muscle weakness and characteristic features of disease. The risk of complications associated with increased progression. Morbidity and mortality caused by scoliosis in neuromuscular diseases can be reduced by increasing the knowledge and awareness of the caregivers and physiotherapists. In this study, it was aimed to determine the risk of neuromuscular scoliosis and the factors which can cause in children with disabilities. It is also aimed to reveal inferences related to education levels, awareness of caregivers and professionals working in this field to determine cases with a high risk of scoliosis. Thus, it is expected to leading future research to develop preventive treatment approaches. For this purpose, 288 children who are diagnosed with the neuromuscular disease between 3-18 years of age, attending Rehabilitation Center in Istanbul and willing to participate in the research permitted by their caregiver will be included in this study. Cerebral Palsy Follow-Up Program (CPUP), Parents and Professionals Awareness Questionnaire related to Neuromuscular Scoliosis which is prepared by researchers, Early Onset Scoliosis 24 Questionnaire, Scoliosis Research Society 22 Questionnaire to assess QoL, demographic and clinical data also will collect for all sample. Patients will be examined for musculoskeletal system, scoliosis analysis will be performed radiologically. Data obtained to determine the problems, risk factors, and awareness of the caregivers and physiotherapists will be analyzed statistically.

Conditions

  • Neuromuscular Scoliosis
  • Deformity

Sponsors & Collaborators

  • Medipol University

    collaborator OTHER

  • Istanbul Rumeli University

    collaborator OTHER

  • Halic University

    lead OTHER

Principal Investigators

  • Özge Ökçü, MSc. · Istanbul Rumeli University

  • Hande Tunc, MSc. · Halic University

  • Ahsen Buyukaslan, PhD.(c) · Medipol University

  • Hürriyet Yılmaz, Prof.Dr. · Halic University

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-09-20
Completion
2022-09-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04764812 on ClinicalTrials.gov